UNSPSC 51453403: Santonin

This classification denotes an antihelminthic agent with the molecular formula C15H18O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1VL8J38ERO, chemically known as 11-epiisoeusantona-1,4-dienic acid, 6alpha-hydroxy-3-oxo-, gamma-lactone but generally known as alpha-santonin, which bears US NIH Compound Identifier 10201. European Medicines Agency schedules Santonin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15192MIG.

As of Q4 2014, SANTONIN remains the US FDA Preferred Term for this commodity. Santonin bears US NLM identifiers UMLS ID C0036179 and NCI Concept Code C87627. SMILES: CC1C2CCC3(C=CC(=O)C(=C3C2OC1=O)C)C.

UNSPSC 51453403 Santonin is a Commodity code that represents pharmaceutical and over-the-counter products, though recent state and local solicitations under this code span a much broader range of health-related supplies and pharmaceuticals than the code name alone suggests. State and local governments are actively procuring naloxone and drug deactivation systems for public health initiatives, generic multi-source pharmaceuticals and OTC products for distribution through cooperative purchasing networks, medical and first aid supplies for emergency response operations, and exploring direct-to-manufacturer prescription fulfillment models to improve cost management and delivery efficiency. The issuing bodies include county health departments, state health and human services commissions, municipal fire departments, and cooperative purchasing alliances that aggregate demand across multiple jurisdictions and states. Recent opportunities reflect operational procurement by direct service providers—emergency response agencies and health departments—as well as strategic purchasing vehicles designed to serve multiple public entities simultaneously.

Activity under this code appears concentrated in Florida and across multistate cooperative purchasing networks, with recent solicitations from Seminole County (naloxone and drug deactivation systems, IFB60459723LAS, due July 26, 2023), the City of Tampa (medical and first aid supplies for the Fire Department, 26P00145, estimated contract value $700,000.00, due March 13, 2026), the Texas Health and Human Services Commission (therapeutic pharmacy initiative direct-to-manufacturer prescriptions RFI, HHS0017013, due April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance (generic pharmaceuticals and OTC products, S1070000015802, due March 26, 2026). The Minnesota cooperative procurement explicitly serves multiple states including Oregon and leverages three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) with contract effectiveness July 1, 2026. The City of Tampa's procurement is designated a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount. Recent activity suggests sustained demand for inventory replenishment, emergency-response consumables, and strategic direct-sourcing models aimed at reducing intermediaries and managing pharmaceutical costs across state and local health systems.